The shortcomings of the RECIST study in HCC
Ghassan Abou-Alfa, MD, MBA, explains the shortcomings of the RECIST study in measuring efficacy in hepatocellular carcinoma (HCC) patients at ASCO 2018.
Author: obr
Added: 07/20/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts